A new drug that enhances the body’s own blood pressure–lowering machinery has shown effectiveness in a large test, researchers reported online March 16 in the Lancet. The results have set the stage for a trial needed for regulatory approval in which the drug will be tested in heart failure patients, who are likely to benefit from its vessel-relaxing effects.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.